Virpax Pharmaceuticals Inc (VRPX)
$0.47
+0.01
(+2.39%)▲
Performance
- $0.47$0.49$0.47
0.0%
Downside
Day's Volatility :3.29%
Upside
3.29%
- $0.46$8.48$0.47
3.19%
Downside
52 Weeks Volatility :94.64%
Upside
94.46%
Returns
| Period | Virpax Pharmaceuticals Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -72.46% | 0.0% |
6 Months | -87.26% | 0.0% |
1 Year | -94.1% | 0.0% |
3 Years | -98.92% | -20.3% |
Highlights
Market Capitalization | 2.3M |
Book Value | - $0.98 |
Earnings Per Share (EPS) | -13.25 |
Wall Street Target Price | 3.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -91.42% |
Return On Equity TTM | -362.29% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -13.25 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -3.3 |
EPS Estimate Next Year | -0.9 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 538.3%
Technicals Summary
Sell
Neutral
Buy
Virpax Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Virpax Pharmaceuticals Inc | -42.5% | -87.26% | -94.1% | -98.92% | -99.3% |
 Regeneron Pharmaceuticals, Inc. | -12.48% | 8.55% | 19.49% | 82.88% | 232.15% |
 Novo Nordisk A/s | -13.09% | -6.28% | 18.91% | 138.88% | 358.83% |
 Alnylam Pharmaceuticals, Inc. | 6.38% | 83.19% | 66.02% | 36.22% | 252.82% |
 Vertex Pharmaceuticals Incorporated | 0.3% | 18.97% | 30.36% | 165.15% | 176.17% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Virpax Pharmaceuticals Inc | NA | NA | NA | -3.3 | -3.62 | -0.91 | NA | -0.98 |
Regeneron Pharmaceuticals, Inc. | 26.81 | 26.81 | 1.38 | 45.04 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 39.53 | 39.53 | 1.79 | 3.39 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.38 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.58 | 0.33 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Virpax Pharmaceuticals Inc | Buy | $2.3M | -99.3% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $111.6B | 232.15% | 26.81 | 32.04% |
Novo Nordisk A/s | Buy | $519.8B | 358.83% | 39.53 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $35.8B | 252.82% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $122.9B | 176.17% | 32.84 | -4.74% |
Insights on Virpax Pharmaceuticals Inc
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.0% return, outperforming this stock by 160.1%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 36.2% return, outperforming this stock by 135.1%
Institutional Holdings
Warberg Asset Management LLC
0.41%Tower Research Capital LLC
0.06%UBS Group AG
0.02%
Company Information
virpax pharmaceuticals specializes in developing new drug delivery systems across various indications to increase compliance and maximize the ability to achieve full therapeutic efficacy. we develop branded pharmaceutical products for pain management by using cutting-edge technology to enhance patients' quality of life, all while creating value for our investors and partners. we are focused on becoming a global leader in non-opioid pain management by developing and delivering innovative pharmaceutical products to our customers. virpax is committed to collaborating with its network of u.s. and global partners to advance the development of proprietary drug platforms that will produce the next generation of branded pharmaceutical products.
Organization | Virpax Pharmaceuticals Inc |
Employees | 7 |
CEO | Mr. Gerald W. Bruce |
Industry | Miscellaneous |
Discover More
Centuri Holdings Inc.
$0.47
+2.39%
Australian Oilseeds Holdings
$0.47
+2.39%
Defe Dly Tr 1.75x L Mstr Etf
$0.47
+2.39%
Hartford Multifactor Small C
$0.47
+2.39%
Proshares Decline Of The Ret
$0.47
+2.39%
United Homes Group Inc
$0.47
+2.39%
Mairs & Power Minnesota Municipal Bond Etf
$0.47
+2.39%
Sim Acquisition Corp I-a
$0.47
+2.39%
Leadershares Dynamic Yield E
$0.47
+2.39%